.Pharmacolibrary.Drugs.V_Various.V10X_OtherTherapeuticRadiopharmaceuticals.V10XA03_Iodine131iOmburtamab.Iodine131iOmburtamab

Information

name:Iodine131iOmburtamab
ATC code:V10XA03
route:intraventricular
n-compartments1

Iodine (131I) omburtamab is a radiolabeled monoclonal antibody targeting B7-H3 (CD276) used as a radioimmunoconjugate in the treatment of central nervous system/leptomeningeal metastasis from neuroblastoma. It delivers targeted radiotherapy to tumors expressing B7-H3. As of 2024, it has been investigated in clinical trials and received an FDA Complete Response Letter and is not widely approved.

Pharmacokinetics

Estimated pharmacokinetic parameters for typical pediatric or adolescent neuroblastoma patients (median age 5–8 years) after intraventricular administration.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos